← Browse by Condition
Medical Condition
kidney neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4
ClinicalMetric aggregates all active clinical trials for kidney neoplasm from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.
- Recruiting trials — currently enrolling participants, with eligibility criteria
- Phase 1–4 studies — from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary for every trial listing
NCT06903312 Phase 4
Recruiting
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Enrollment
409 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT07234409
Recruiting
Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma
Enrollment
124 pts
Location
Italy
Sponsor
Niguarda Hospital